-
1
-
-
12144289701
-
Guidelines for the treatment (pharmacotherapy) of osteoporosis: Year 2000 revision
-
Orimo H, Ohta H, Kishimoto H, Shiraki M, Suzuki T, Takaoka K, Nakamura T, Nishizawa Y, Hagino H, Hayashi Y, Hirota T, Fukunaga M, Hosoi T, Matsumoto T, Miki T, Yoh K, Wada S (2002) Guidelines for the treatment (pharmacotherapy) of osteoporosis: year 2000 revision (in Japanese). Osteoporosis Jpn 10:635-709
-
(2002)
Osteoporosis Jpn
, vol.10
, pp. 635-709
-
-
Orimo, H.1
Ohta, H.2
Kishimoto, H.3
Shiraki, M.4
Suzuki, T.5
Takaoka, K.6
Nakamura, T.7
Nishizawa, Y.8
Hagino, H.9
Hayashi, Y.10
Hirota, T.11
Fukunaga, M.12
Hosoi, T.13
Matsumoto, T.14
Miki, T.15
Yoh, K.16
Wada, S.17
-
2
-
-
0034765632
-
Diagnostic criteria for primary osteoporosis: Year 2000 revision
-
Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331-337
-
(2001)
J Bone Miner Metab
, vol.19
, pp. 331-337
-
-
Orimo, H.1
Hayashi, Y.2
Fukunaga, M.3
Sone, T.4
Fujiwara, S.5
Shiraki, M.6
Kushida, K.7
Miyamoto, S.8
Soen, S.9
Nishimura, J.10
Oh-Hashi, Y.11
Hosoi, T.12
Gorai, I.13
Tanaka, H.14
Igai, T.15
Kishimoto, H.16
-
3
-
-
0034765085
-
Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
-
Nishizawa Y, Nakamura T, Ohata H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Nakatsuka K, Miura M (2001) Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001). J Bone Miner Metab 19:338-344
-
(2001)
J Bone Miner Metab
, vol.19
, pp. 338-344
-
-
Nishizawa, Y.1
Nakamura, T.2
Ohata, H.3
Kushida, K.4
Gorai, I.5
Shiraki, M.6
Fukunaga, M.7
Hosoi, T.8
Miki, T.9
Nakatsuka, K.10
Miura, M.11
-
4
-
-
1642510831
-
Specificity of bisphosphonates' effect and bone metabolism
-
Fujita T (ed). Life Science Publishing, Tokyo
-
Kawashima H (1993) Specificity of bisphosphonates' effect and bone metabolism. In: Fujita T (ed) Osteoporosis: diagnosis and treatment (in Japanese). Life Science Publishing, Tokyo, pp 397-408
-
(1993)
Osteoporosis: Diagnosis and Treatment (in Japanese)
, pp. 397-408
-
-
Kawashima, H.1
-
5
-
-
0024816838
-
Antiresorptive dose-response relationships across three generations of bisphosphonates
-
Sietsema WK, Ebetino FH, Salvagno AM, Bevan JA (1989) Antiresorptive dose-response relationships across three generations of bisphosphonates. Drugs Exp Clin Res 15:389-396
-
(1989)
Drugs Exp Clin Res
, vol.15
, pp. 389-396
-
-
Sietsema, W.K.1
Ebetino, F.H.2
Salvagno, A.M.3
Bevan, J.A.4
-
6
-
-
0025334778
-
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
-
Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC, Yanover MJ, Mysiw WJ, Kohse L, Rao MB, Steiger P, Richmond B, Chesnut CH III (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323:73-79
-
(1990)
N Engl J Med
, vol.323
, pp. 73-79
-
-
Watts, N.B.1
Harris, S.T.2
Genant, H.K.3
Wasnich, R.D.4
Miller, P.D.5
Jackson, R.D.6
Licata, A.A.7
Ross, P.8
Woodson, G.C.9
Yanover, M.J.10
Mysiw, W.J.11
Kohse, L.12
Rao, M.B.13
Steiger, P.14
Richmond, B.15
Chesnut III, C.H.16
-
7
-
-
0001320677
-
Double-blind multicenter comparative study with alfacalcidol of etidronate disodium (EHDP) in involutional osteoporosis
-
Fujita T, Orimo H, Inoue T, Kaneda K, Sakurai M, Morita R, Morii H, Yamamoto K, Sugioka Y, Inoue A, Hoshino Y, Kawaguchi H, Yamamoto I, Fukase M, Takaoka K (1993) Double-blind multicenter comparative study with alfacalcidol of etidronate disodium (EHDP) in involutional osteoporosis (in Japanese). Clin Eval 21:261-302
-
(1993)
Clin Eval
, vol.21
, pp. 261-302
-
-
Fujita, T.1
Orimo, H.2
Inoue, T.3
Kaneda, K.4
Sakurai, M.5
Morita, R.6
Morii, H.7
Yamamoto, K.8
Sugioka, Y.9
Inoue, A.10
Hoshino, Y.11
Kawaguchi, H.12
Yamamoto, I.13
Fukase, M.14
Takaoka, K.15
-
8
-
-
0028851590
-
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
-
Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora AC, Lombardi A, Shah RV, Hirsch LJ, Karpf DB (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437-1444
-
(1995)
N Engl J Med
, vol.333
, pp. 1437-1444
-
-
Liberman, U.A.1
Weiss, S.R.2
Bröll, J.3
Minne, H.W.4
Quan, H.5
Bell, N.H.6
Rodriguez-Portales, J.7
Downs, R.W.8
Dequeker, J.9
Favus, M.10
Seeman, E.11
Recker, R.R.12
Capizzi, T.13
Santora, A.C.14
Lombardi, A.15
Shah, R.V.16
Hirsch, L.J.17
Karpf, D.B.18
-
9
-
-
7144251176
-
A placebo controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis
-
Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Kaneda K, Minaguchi H, Inoue T, Tomita A, Nagata Y, Nakashima M, Orimo H (1998) A placebo controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. Endocr J 45:191-201
-
(1998)
Endocr J
, vol.45
, pp. 191-201
-
-
Shiraki, M.1
Kushida, K.2
Fukunaga, M.3
Kishimoto, H.4
Kaneda, K.5
Minaguchi, H.6
Inoue, T.7
Tomita, A.8
Nagata, Y.9
Nakashima, M.10
Orimo, H.11
-
10
-
-
0034145470
-
Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteers
-
Mitchell DY, Eusebio RA, Sacco-Gibson NA, Pallone KA, Kelly SC, Nesbitt JD, Brezovic CP, Thompson GA, Powell JH (2000) Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteers. J Clin Pharmacol 40:258-265
-
(2000)
J Clin Pharmacol
, vol.40
, pp. 258-265
-
-
Mitchell, D.Y.1
Eusebio, R.A.2
Sacco-Gibson, N.A.3
Pallone, K.A.4
Kelly, S.C.5
Nesbitt, J.D.6
Brezovic, C.P.7
Thompson, G.A.8
Powell, J.H.9
-
11
-
-
0004646069
-
Validation of an enzyme linked immunosorbent assay for the determination of risedronate in human serum
-
DeSilva BS, Whitham DJ, Bhullar B, Kamra LC, DeStefano AJ (1998) Validation of an enzyme linked immunosorbent assay for the determination of risedronate in human serum. AAPS PharmSci 1:S26. http://www.aapspharmsci.org/
-
(1998)
AAPS PharmSci
, vol.1
-
-
DeSilva, B.S.1
Whitham, D.J.2
Bhullar, B.3
Kamra, L.C.4
DeStefano, A.J.5
-
12
-
-
85037013374
-
Risedronate dose-dependently decreases bone turnover in ovariectomized minipigs
-
Gropp KE, Bouchard GF, Phipps RJ, Smith PN (1997) Risedronate dose-dependently decreases bone turnover in ovariectomized minipigs. J Bone Miner Res 12 (suppl 1):S471
-
(1997)
J Bone Miner Res
, vol.12
, Issue.SUPPL. 1
-
-
Gropp, K.E.1
Bouchard, G.F.2
Phipps, R.J.3
Smith, P.N.4
|